Clinical Evaluation of Polarized Light Assisted Colposcopy

NCT ID: NCT01349621

Last Updated: 2015-03-10

Basic Information

• Recruitment Status: COMPLETED
• Total Enrollment: 330 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2011-04-30
• Study Completion Date: 2014-02-28

Brief Summary

This is a prospective study to compare unpolarized (conventional) to polarized light colposcopy. Subjects will be asked to participate in the study when they arrive for their prescheduled colposcopic examination. The study doctor will use a conventional or standard colposcope to perform the examination. His/her impression of the exam will be noted and if necessary a biopsy specimen will be obtained. The study doctor will then perform a colposcopy using a polarized light. His/her impression of the exam will be noted and a biopsy specimen will be obtained if necessary.

This study is designed to test the hypothesis that polarized light colposcopy is more sensitive and more specific than standard, un-polarized light colposcopy.

Detailed Description

Women scheduled for a colposcopic examination at GRU or CerviCusco were asked to participate in the study. Interested patients read and signed an IRB-approved Informed Consent Document (ICD) that described the study and their potential involvement. The study coordinator read and or translated the ICD to women who spoke languages other than English or Spanish (i.e. Quechua).

Pertinent disease specific demographic information was collected from each patient. Following insertion of a vaginal speculum and a one minute application of 5% acetic acid, polarized and non-polarized high resolution digital RGB images were taken of the ectocervix. Thereafter, non-polarized light colposcopy was performed as standard of care. The colposcopist derived a colposcopic impression and indicated whether a biopsy was necessary. So as not to compromise the next examination, Lugol's Iodine was not applied. Then, a polarized light colposcopy was performed. As before, the colposcopist derived an impression, indicated whether a biopsy was necessary and annotated the site of pending biopsy. Then if indicated, a minimum of one cervical biopsy was obtained from the area(s) representing the most severe colopscopic changes as seen during the non-polarized exam. The exact biopsy site was annotated.

Conditions

Cervical Intraepithelial Neoplasia

Study Design

• Study Time Perspective: PROSPECTIVE

Study Groups

Standard and polarized light colposcopy

Standard and polarized light colposcopy

No interventions assigned to this group

Eligibility Criteria

Inclusion Criteria

• Subject is female, 18 years or older
• Subject has previously detected abnormal cervical cytology or other indication for colposcopy
• Subject fully understands study procedures, alternative treatments available, the risks involved with the study, and voluntarily agrees to participate by giving written informed consent

Exclusion Criteria

• Subject is pregnant or may be pregnant
• Subject has known allergy to acetic acid
• Subject has thrombocytopenia or other coagulation disorder that would contraindicate obtaining multiple cervical biopsies
• Subject is concurrently enrolled in clinical studies of investigational agents or studies involving collection of cervical specimens
• Subject has a history or current evidence of any condition, therapy, lab abnormality or other circumstance that might confound the results of the study, or interfere with the subject's participation for the full duration of the study, such that it is not in the best interest of the subject to participate
• Subject has clinical evidence of gross purulent cervicitis
• Subject has a recent history of acute cervicitis
• Subject does not have an intact cervix uteri or has more than one cervix uteri

• Minimum Eligible Age: 18 Years
• Eligible Sex: FEMALE
• Accepts Healthy Volunteers: Yes

Sponsors

National Institutes of Health (NIH)

NIH

Sponsor Role: collaborator

National Cancer Institute (NCI)

NIH

Sponsor Role: collaborator

Augusta University

OTHER

Sponsor Role: lead

Responsible Party

Daron Ferris

Professor, Department of Family Medicine and Obstetrics and Gynecology

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Daron Ferris, MD

Role: PRINCIPAL_INVESTIGATOR

Geogia Health Sciences University

Locations

Georgia Health Sciences University

Augusta, Georgia, United States

Countries

United States

Other Identifiers

1R21CA156166-01A1

Identifier Type: NIH

Identifier Source: secondary_id

View Link

CA156166

Identifier Type: -

Identifier Source: org_study_id